Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00336
|
|||||
| Drug Name |
Hematoporphyrin
|
|||||
| Synonyms |
1,3,5,8-Tetramethyl-2,4-bis(alpha-hydroxyethyl)prophine-6,7-dipropionic acid; 2,18-Porphinedipropionic acid, 7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-; 21H,23H-Porphine-2,18-dipropanoic acid, 7,12-bis(1-hydroxyethyl); 7,12-Bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoic acid; HEMATOPORPHYRIN; HP; HP (VAN); Haematoporphyrin; Hematoporphyrin I; Hematoporphyrin IX; ISOHEMATOPORPHYRIN IX; NSC 267084; NSC 59265; NSC59265; Photodyn
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Therapeutic Class |
Antiasthenia Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C34H38N4O6
|
|||||
| Canonical SMILES |
CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)O)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O
|
|||||
| InChI |
InChI=1S/C34H38N4O6/c1-15-21(7-9-31(41)42)27-14-28-22(8-10-32(43)44)16(2)24(36-28)12-29-34(20(6)40)18(4)26(38-29)13-30-33(19(5)39)17(3)25(37-30)11-23(15)35-27/h11-14,19-20,37-40H,7-10H2,1-6H3,(H,41,42)(H,43,44)
|
|||||
| InChIKey |
KFKRXESVMDBTNQ-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 14459-29-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 598.7 | Topological Polar Surface Area | 172 | ||
| Heavy Atom Count | 44 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
2.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:36162
|
|||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [1] | |
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | BCRP | Transporter Info | Km = 17.8 microM | Spodoptera frugiperda (Sf9) cells-BCRP | [2] | |
| References | ||||||
| 1 | Cellular phototoxicity evoked through the inhibition of human ABC transporter ABCG2 by cyclin-dependent kinase inhibitors in vitro. Pharm Res. 2009 Feb;26(2):449-58. | |||||
| 2 | Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport. Mol Pharmacol. 2006 Jul;70(1):287-96. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.